Back
ESC Premium Access

State of the art in therapeutic modulation of the immune response in atherosclerosis

Session: Therapeutic modulation of the immune response in atherosclerosis
Topic: Atherosclerosis
Speaker: Professor P. Libby (Boston, US)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
37 presentations
7 followers

4 more presentations in this session

Nanoparticle-enabled RNAi in endothelial cells attenuates inflammation in atherosclerosis and acute myocardial infarction

Speaker: Doctor H. Sager (Munich, DE)

Access
Abstract
Like
Thumbnail

STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells

Speaker: Doctor L. Xu (Shanghai, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Bone marrow-specific Sirt6 deletion enhances atherosclerosis and foam cell formation via an increase in macrophage scavenger receptor 1 expression

Speaker: Miss T. Arsiwala (Zurich, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Future direction for research in therapeutic modulation of the immune response in atherosclerosis.

Speaker: Professor J. Nilsson (Malmo, SE)

Access
Slides
Video
Like
Thumbnail

Access the full session

Therapeutic modulation of the immune response in atherosclerosis

Speakers: Professor P. Libby, Doctor H. Sager, Doctor L. Xu, Miss T. Arsiwala, Professor J. Nilsson
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources